Finance

Beta
Lists
THAT:LON
Thalia Therapeutics PLC
GBX 0.60
+4.35%
(+0.025) 1D
Jun 17, 3:04:11 PM GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for THAT...
Open
GBX 0.55
High
GBX 0.60
Low
GBX 0.55
Mkt. cap
4.79M
Avg. vol.
841.72K
Volume
171.50K
52-wk high
GBX 0.95
52-wk low
GBX 0.40
Shares outstanding
832.28M
No. of employees
4
Open
GBX 0.55
High
GBX 0.60
Low
GBX 0.55
Mkt. cap
4.79M
Avg. vol.
841.72K
Volume
171.50K
52-wk high
GBX 0.95
52-wk low
GBX 0.40
Shares outstanding
832.28M
No. of employees
4
News stories
From sources across the web
About Thalia Therapeutics PLC
CEO-
Employees4
Founded1979
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in GBP
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in GBP
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
1.69K
1.69K
1.84K
1.84K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
138.18K
138.18K
33.66K
33.66K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
229.04K
229.04K
203.30K
203.30K
Operating expense
367.22K
367.22K
236.95K
236.95K
Total operating expenses
367.22K
367.22K
236.95K
236.95K
Operating income
-365.53K
-365.53K
-235.11K
-235.11K
Other non operating income
-
-
-
-
EBT including unusual items
-364.70K
-364.70K
-235.11K
-235.11K
EBT excluding unusual items
-364.70K
-364.70K
-235.11K
-235.11K
Income tax expense
-50.56K
-50.56K
15.69K
15.69K
Effective tax rate
13.86%
13.86%
-6.67%
-6.67%
Other operating expenses
-
-
-
-
Net income
-301.88K
-301.88K
-249.28K
-249.28K
Net profit margin
-17,883.71%
-17,883.71%
-13,510.84%
-13,510.84%
Earnings per share
-
-
-
-
Interest and investment income
829.00
829.00
-
-
Interest expense
-
-
-
-
Net interest expenses
829.00
829.00
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more